Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
pregabalin, Quantity: 50 mg
Lupin Australia Pty Limited
Pregabalin
Capsule, hard
Excipient Ingredients: pregelatinised maize starch; purified talc; titanium dioxide; purified water; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute
Oral
20, 14, 56, 60
(S4) Prescription Only Medicine
Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Visual Identification: Size '4' capsules with white cap and white body, imprinted with "PG" on the cap and with a band and with "50" on the body in black ink, containing white to off white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-12-05